897657-00-0

Upstream product

• 897656-78-9 2-ethoxy-6,7,8,9-tetrahydro-4H-naphtho[2,3-d][1,3]oxazin-4-one 
• 104877-13-6 3-amino-5,6,7,8-tetrahydro-napthalene-2-carboxylic acid 
• 5959-52-4 2-Amino-3-naphthoic acid 
• 897656-81-4 3-methyl-2,5,7,8,9,10-hexahydro-4H-benzo[g]pyrazolo[4,3-c]quinolin-4-one 
• 100-39-0 benzyl bromide 

Downstream Products

• 897657-01-1 tert-butyl 3-(2-benzyl-3-methyl-4-oxo-2,4,7,8,9,10-hexahydro-4H-benzo[g]pyrazolo[4,3-c]quinolin-5-yl)propylcarbamate 
• 897657-27-1 2-benzyl-3-methyl-5-(oxiran-2-ylmethyl)-2,5,7,8,9,10-hexahydro-4H-benzo[g]pyrazolo[4,3-c]qumolin-4-one 
• 897657-28-2 5-(3-azido-2-hydroxypropyl)-2-benzyl-3-methyl-2,5,7,8,9,10-hexahydro-4H-benzo[g]pyrazolo[4,3-c]quinolin-4-one 
• 897657-03-3 N-[3-(2-benzyl-3-methyl-4-oxo-2,4,7,8,9,10-hexahydro-4H-benzo[g]pyrazolo[4,3-c]quinolin-5-yl)propyl]methanesulfonamide 
• 943819-58-7 tert-butyl 3-(2-benzyl-3-methyl-4-oxo-2,4,7,8,9,10-hexahydro-5H-benzo[g]pyrazolo[4,3-c]quinolin-5-yl)-2-fluoropropylcarbamate 

Relevant academic research and scientific papers

INHIBITORS OF CHECKPOINT KINASES

The instant invention provides for compounds which comprise fused pyrazoles that inhibit CHK1 activity. The invention also provides for compositions comprising such inhibitory compounds and methods of inhibiting CHK1 activity by administering the compound

INHIBITORS OF CHECKPOINT KINASES

The instant invention provides for compounds which comprise fused pyrazoles that inhibit CHK1 activity. The invention also provides for compositions comprising such inhibitory compounds and methods of inhibiting CHK1 activity by administering the compound